Nurix Therapeutics, Inc. (NRIX)
NASDAQ: NRIX · Real-Time Price · USD
8.94
+0.37 (4.32%)
Sep 18, 2025, 11:24 AM EDT - Market open
Nurix Therapeutics Market Cap
Nurix Therapeutics has a market cap or net worth of $683.46 million as of September 18, 2025. Its market cap has decreased by -57.89% in one year.
Market Cap
683.46M
Enterprise Value
221.32M
1-Year Change
-57.89%
Ranking
Category
Stock Price
$8.94
Market Cap Chart
Since July 24, 2020, Nurix Therapeutics's market cap has decreased from $704.09M to $683.46M, a decrease of -2.93%. That is a compound annual growth rate of -0.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2025 | 655.17M | -50.91% |
| Dec 31, 2024 | 1.33B | 166.61% |
| Dec 29, 2023 | 500.56M | -3.31% |
| Dec 30, 2022 | 517.68M | -59.92% |
| Dec 31, 2021 | 1.29B | 1.09% |
| Dec 31, 2020 | 1.28B | 81.45% |
| Jul 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 682.40B |
| Johnson & Johnson | 426.76B |
| AbbVie | 390.07B |
| UnitedHealth Group | 309.39B |
| Novo Nordisk | 260.64B |
| AstraZeneca | 241.43B |
| Novartis AG | 237.64B |
| Abbott Laboratories | 233.52B |